Does heart Dose be an Independent Dosimetric Predictor of Overall Survival in Locally Advanced Non-Small Cell Lung Cancer?
Heart dose is associated with OS and cardiac toxicity for patients with LA NSCLC treated with chemoradiotherapy.
GBS≤1 has a high NPV for adverse outcomes in UGIB. This suggests outpatient management of patients with UGIB and that GBS≤1 is safe in our population.